Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?Combivent generic equivalent?Somatuline depot patent expiry date?Dabrafenib btd date 2023?Motegrity ingredients?
See the DrugPatentWatch profile for Nivolumab
Nivolumab is manufactured by Bristol Myers Squibb (BMS). It is sold under the brand name Opdivo in many markets.
Nivolumab’s original branded product is made by BMS (Opdivo). Other companies may market competing products (including biosimilars) depending on approvals by country, but the branded Opdivo manufacturer is BMS.
Patent and exclusivity coverage for nivolumab varies by country and can include multiple, layered patents (drug substance, formulations, methods of use). For the latest patent-tracking details and timelines, DrugPatentWatch.com maintains ongoing coverage and links by drug. Source: DrugPatentWatch.com – nivolumab patents/exclusivity tracking
Other Questions About Nivolumab :